1. Home
  2. PZZA vs NBTX Comparison

PZZA vs NBTX Comparison

Compare PZZA & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Papa John's International Inc.

PZZA

Papa John's International Inc.

HOLD

Current Price

$32.19

Market Cap

1.0B

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$31.79

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PZZA
NBTX
Founded
1984
2003
Country
United States
France
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
PZZA
NBTX
Price
$32.19
$31.79
Analyst Decision
Buy
Strong Buy
Analyst Count
8
1
Target Price
$45.00
$26.00
AVG Volume (30 Days)
1.3M
24.7K
Earning Date
05-25-2026
01-01-0001
Dividend Yield
5.87%
N/A
EPS Growth
N/A
N/A
EPS
0.90
N/A
Revenue
$2,068,421,000.00
N/A
Revenue This Year
$1.13
N/A
Revenue Next Year
$0.96
$11.73
P/E Ratio
$34.62
N/A
Revenue Growth
14.07
N/A
52 Week Low
$30.16
$2.95
52 Week High
$55.74
$31.49

Technical Indicators

Market Signals
Indicator
PZZA
NBTX
Relative Strength Index (RSI) 41.61 74.91
Support Level $30.18 $20.11
Resistance Level $40.23 N/A
Average True Range (ATR) 1.59 1.69
MACD 0.07 0.63
Stochastic Oscillator 37.75 82.42

Price Performance

Historical Comparison
PZZA
NBTX

About PZZA Papa John's International Inc.

Papa John's is one of the largest players in the global QSR, or quick-service restaurant, pizza market, boasting more than 6,000 restaurants across nearly 50 countries at the end of 2024. The firm operates a predominantly franchised system, owning 9% of its restaurants and generating revenue from franchise royalties, sales of pizza and related products at its company-owned stores, and sales from its commissary supply chain. The firm is the fourth-largest limited-service pizza chain globally and third in the US (Euromonitor International), with a sizable presence in the UK, China, South Korea, and Chile.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: